The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of hepatic and extrahepatic cancers, in particular those linked to obesity. In people with chronic liver disease, aspirin may confer protection against hepatocellular carcinoma (HCC). We explore t...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Matthew Anson, Jun Shang Poon, Alex E. Henney, David Riley, Gema H. Ibarbaru, Cyril Sieberhagen, Daniel J. Cuthbertson, Uazman Alam, Theresa Hydes
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2024-12-01
سلاسل:	BMC Medicine
الموضوعات:	Hepatocellular carcinoma Non-alcoholic fatty liver disease Aspirin Anti-platelets Obesity
الوصول للمادة أونلاين:	https://doi.org/10.1186/s12916-024-03802-4
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!